- Home
- CNTA vs PK Comparison
CNTA vs PK Comparison
Compare CNTA & PK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- PK
- Stock Information
- Founded
- CNTA 2020
- PK 1946
- Country
- CNTA United Kingdom
- PK United States
- Employees
- CNTA N/A
- PK N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- PK Real Estate Investment Trusts
- Sector
- CNTA Health Care
- PK Real Estate
- Exchange
- CNTA Nasdaq
- PK Nasdaq
- Market Cap
- CNTA 2.3B
- PK 2.0B
- IPO Year
- CNTA 2021
- PK N/A
- Fundamental
- Price
- CNTA $22.92
- PK $10.14
- Analyst Decision
- CNTA Strong Buy
- PK Hold
- Analyst Count
- CNTA 9
- PK 11
- Target Price
- CNTA $31.75
- PK $12.27
- AVG Volume (30 Days)
- CNTA 1.3M
- PK 3.7M
- Earning Date
- CNTA 11-05-2025
- PK 10-30-2025
- Dividend Yield
- CNTA N/A
- PK 9.84%
- EPS Growth
- CNTA N/A
- PK N/A
- EPS
- CNTA N/A
- PK N/A
- Revenue
- CNTA $15,000,000.00
- PK $2,541,000,000.00
- Revenue This Year
- CNTA N/A
- PK $0.42
- Revenue Next Year
- CNTA N/A
- PK $2.10
- P/E Ratio
- CNTA N/A
- PK N/A
- Revenue Growth
- CNTA 118.88
- PK N/A
- 52 Week Low
- CNTA $9.60
- PK $8.27
- 52 Week High
- CNTA $25.42
- PK $16.23
- Technical
- Relative Strength Index (RSI)
- CNTA 48.74
- PK 35.16
- Support Level
- CNTA $17.05
- PK $9.89
- Resistance Level
- CNTA $25.35
- PK $11.52
- Average True Range (ATR)
- CNTA 1.47
- PK 0.35
- MACD
- CNTA -0.21
- PK -0.09
- Stochastic Oscillator
- CNTA 71.72
- PK 17.92
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About PK Park Hotels & Resorts Inc.
Park Hotels & Resorts owns upper-upscale and luxury hotels, with 22,395 rooms across 36 hotels in the United States. Park also has interests through joint ventures in another 2,271 rooms in three US hotels. Park was spun out of Hilton Worldwide Holdings at the start of 2017, so most of its hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.